Vera Therapeutics (VERA)
(Delayed Data from NSDQ)
$37.39 USD
-0.23 (-0.61%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $37.41 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | -5.66% |
ABR | 1.22 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.34 |
Next Year | -2.56 |
EPS (TTM) | -2.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.60 | -2.34 | -2.56 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.67 | -0.69 | -2.25 | -2.40 |
High Estimate | -0.52 | -0.54 | -2.17 | -2.15 |
Low Estimate | -0.67 | -0.69 | -2.60 | -3.31 |
Year ago EPS | -0.46 | -0.45 | -2.25 | -2.34 |
Year over Year Growth Est. | -26.09% | -33.33% | -4.00% | -9.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.60 | -2.34 | -2.56 |
7 Days Ago | -0.58 | -0.60 | -2.34 | -2.56 |
30 Days Ago | -0.58 | -0.60 | -2.34 | -2.56 |
60 Days Ago | -0.58 | -0.60 | -2.34 | -2.56 |
90 Days Ago | -0.55 | -0.57 | -2.18 | -2.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.58 | -0.60 | -2.34 | -2.56 |
Zacks Consensus Estimate | -0.58 | -0.60 | -2.34 | -2.56 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.58 | -0.45 | -0.46 | NA |
Estimate | -0.53 | -0.53 | -0.50 | -0.69 | NA |
Difference | -0.03 | -0.05 | 0.05 | 0.23 | 0.05 |
Surprise | -5.66% | -9.43% | 10.00% | 33.33% | 7.06% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more